La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Central Garden & Pet a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Central Garden & Pet..

Central Garden & Pet (NASDAQ:CENT) Azioni, Catena delle Opzioni

Central Garden & Pet

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

CENTENNIAL SPECIALTY FOOD by Centennial Specialty Foods Corp.

CENTERGISTIC SLTNS INC by Centergistic Solutions, Inc.

CENTOGENE NV ORD

CENTR Brands Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

CENTRAL CHINA SECS S/ADR by Central China Securities Co. Ltd.

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

CENTRAL NEW ENERGY HLDG by CENTRAL NEW ENERGY HLDG GROUP LTD.

Centamin PLC

Centaur Media PLC

CENTAURUS ENERGY INC by Centaurus Energy Inc.

Centaurus Energy Inc

CENTAURUS METALS LTD ORD by Centaurus Metals Ltd.

Centaurus Metals Ltd

CENTENARIO GOLD CORP by CENTENARIO GOLD CORP.

Centenario Gold Corp

Centene Corp

CenterPoint Energy, Inc (Holding Co) Common Stock

CenterPoint Energy Inc

Centerra Gold Inc

Centerspace

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals PLC

Centogene NV

Centor Energy Inc

Centrais Electricas Brasileiras S.A. Sponsored ADS representing Pfd Shares

Centrais Eletricas Brasileiras SA

Centrais Electricas Brasileiras S A American Depositary Shares (Each representing one Common Share)

CENTRAL ASIA METALS LTD by Central Asia Metals Ltd, London

Central Asia Metals PLC

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

Central Automotive Products Ltd

Central Bancompany

CENTRAL BANCO B NON VTG by Central Bancompany

Central Bank Corp

CENTRAL CHINA MGMT CO LTD by CENTRAL CHINA MGMT CO LTD.

Central China Management Co Ltd

CENTRAL CHINA R E LTD ORD by Central China Real Estate Limited

Central China Real Estate Ltd

Central Energy Partners LP

CENTRAL GLASS CO LTD ORD by Central Glass Co., Ltd.

Central Glass Co Ltd

CENTRAL IRON ORE LIMITED by CENTRAL IRON ORE LIMITED

Central Iron Ore Ltd

CENTRAL JAPAN RY ORD by Central Japan Railway Co.

Central Japan Railway Co

CENTRAL JAPAN RY UNSP/ADR by Central Japan Railway Co.

CENTRAL NATURAL RES INC by Central Natural Resources, Inc.

Central Natural Resources Inc

Central Pacific Financial Corp

CENTRAL PRKNG F/T 5.25PFD by Central Parking Finance Trust

Central Parking Financial Trust

Central Pattana PCL Units Non-Voting Depository Receipt

Central Pattana PCL

CENTRAL PATTANA PUB CO by Central Pattana Plc.

CENTRAL PATTANA PLC ADR by Central Pattana Plc.

CENTRAL PETROLEUM LTD by Central Petroleum Ltd.

Central Petroleum Ltd

Central Plains Bancshares, Inc. - Common Stock

Central Plains Bancshares Inc

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Central Securities Corporation Common Stock

Central Securities Corp

CENTRAL WIRELESS INC by Central Wireless, Inc.

Central Wireless Inc

Centrenergo PJSC

Centrica PLC

Centrifuge - United States Dollar

Centrus Energy Corp. Class A Common Stock

Centrus Energy Corp

Centuri Holdings Inc

Centuria Capital Group

CENTURIA IND REIT ORD UTS by Centuria Indl Reit

Centuria Industrial REIT

Centurion Acquisition Corp

Centurion Acquisition Corp. - Class A Ordinary Shares

Century Aluminum Co

Century Casinos Inc

CENTURY COBALT CORP by Century Cobalt Corp.

Century Cobalt Corp

Century Communities Inc

CENTURY FINCL CORP MI by Century Financial Corp.

Century Financial Corp

CENTURY GLOBAL COM NEW by Century Global Commodities Corp

Century Global Commodities Corp

CENTURY LITHIUM CORP by CENTURY LITHIUM CORP.

Century Lithium Corp

CENTURY NEXT FINANCIAL CP by Century Next Financial Corp

Century Next Financial Corp

CENTURY PETROLEUM CORP by Century Petroleum Corp.

Century Petroleum Corp

Century Therapeutics, Inc. - Common Stock

Century Therapeutics Inc

Truist Securities analyst Bill Chappell maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) with a Buy and lowers the price target from $50 to $40.

News

Price Target

Analyst Ratings

CENT

Truist Securities Maintains Buy on Central Garden & Pet, Lowers Price Target to $40

Canaccord Genuity analyst Brian McNamara maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) with a Buy and maintains $48 price target.

Canaccord Genuity Maintains Buy on Central Garden & Pet, Maintains $48 Price Target

Niko Lahanas, Former Central CFO, Brings 18 Years of Experience at the Company
Brad Smith, Former CFO, Pet Segment, Appointed Central CFO
Interim CEO and Director Beth Springer to Return to Role of Lead Independent Director
Central Garden &amp; Pet Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>), (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>), ("Central" or "the Company"), a market leader in the Pet and Garden industries, announced today that <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fniko-lahanas%2F&amp;esheet=54127962&amp;newsitemid=20240927935178&amp;lan=en-US&amp;anchor=Niko+Lahanas&amp;index=1&amp;md5=c5360414556d7108604d77cecea22146">Niko Lahanas</a> has been appointed Chief Executive Officer, and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fbradleygsmith8%2F&amp;esheet=54127962&amp;newsitemid=20240927935178&amp;lan=en-US&amp;anchor=Brad+Smith&amp;index=2&amp;md5=ea7f3ee9d4b415755d8ba616d59cc1b7">Brad Smith</a> has been appointed Chief Financial Officer, effective September 29, 2024. Mr. Lahanas will also join Central's Board of Directors. Mr. Lahanas succeeds Beth Springer, who has served as Interim Chief Executive Officer since October, 2023. Ms. Springer will return to the role of Lead Independent Director.

Management

CENTA

Central Garden & Pet Appoints Niko Lahanas As CEO And Brad Smith As CFO; Interim CEO And Director Beth Springer To Return To Role Of Lead Independent Director

A substantial insider sell was reported on September 3, by William E Brown, Chairman at Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>), based on the recent SEC filing.
What Happened: Brown's decision to sell 60,000 shares of Central Garden &amp; Pet was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000887733/000095017024102926//Archives/edgar/data/887733/000095017024102926/0000950170-24-102926-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the sale is $2,012,177.
The latest market snapshot at Wednesday morning reveals Central Garden &amp; Pet shares down by 0.0%, trading at $39.25.
<h3>All You Need to Know About Central Garden &amp; Pet</h3>
Central Garden &amp; Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
<h3>Financial Milestones: Central Garden &amp; Pet's Journey</h3>
Revenue Growth: Central Garden &amp; Pet's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -2.63%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 31.82%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): Central Garden &amp; Pet's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.21.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.87.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 18.09 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 0.8, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Central Garden &amp; Pet's EV/EBITDA ratio, lower than industry averages at 9.53, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Relevance of Insider Transactions</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000887733">Check Out The Full List Of Central Garden &amp; Pet's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

William E Brown Takes Money Off The Table, Sells $2.01M In Central Garden & Pet Stock

As Chewy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) prepares to release its second-quarter fiscal 2024 earnings on Aug 28 before the opening bell, investors are keenly evaluating whether the stock offers a compelling investment opportunity. The pet-centric e-commerce company has attracted significant attention, thanks to its robust growth trajectory and strategic initiatives. However, with the earnings just around the corner, it is crucial to determine whether Chewy remains a wise investment opportunity at this stage.
Chewy&#39;s impressive growth, solid market position and loyal customer base have cemented its popularity among investors. The Zacks Consensus Estimate places revenues at $2.86 billion for the upcoming quarter, suggesting a 2.8% increase from the year-ago period.
On the earnings front, the consensus estimate has held steady at 22 cents a share over the past 30 days, implying a substantial 46.7% year-over-year increase.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/d3/75069.jpg?v=970460867" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
Chewy has a strong track record, with an average earnings surprise of 57.7% over the past four quarters. In the last reported quarter, the company exceeded the Zacks Consensus Estimate by an impressive margin of 47.6%.
<div class="chart_embed">
<h3>Chewy Price, Consensus and EPS Surprise</h3>
<img alt="Chewy Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/e8/1724332285.png" style="height:265px; width:580px" title="" />
Chewy price-consensus-eps-surprise-chart | Chewy Quote
</div>
<h2>What Zacks Model Says About CHWY</h2>
Our proven model predicts that Chewy is likely to beat earnings this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here.
Chewy has an Earnings ESP of +4.55% and carries a Zacks Rank #2. You can uncover the best stocks to buy or sell before they&#39;re reported with our Earnings ESP Filter.
<h2>Factors at Play</h2>
Chewy&#39;s strategic focus on expanding its product offerings and enhancing customer experience is likely to have contributed toward revenue growth. By consistently broadening its inventory with new and exclusive items, Chewy meets evolving customer preferences and needs. This approach, coupled with strategic promotions and targeted marketing initiatives, is anticipated to attract new customers while encouraging increased spending from existing ones.
The Autoship program&#39;s continued success is also expected to have played a crucial role in driving revenues. As the program grows, its convenience and value are likely to lead to higher customer retention and repeat purchases.
The introduction of the Chewy Plus membership program represents another important factor. As this program gains traction, the added benefits, such as free shipping and exclusive discounts, are likely to stimulate higher purchase frequencies and larger basket sizes.
Chewy&#39;s expansion into new markets, particularly its efforts in Canada and other international regions, provides additional revenue growth potential. This geographic diversification opens up new avenues for customer acquisition. Moreover, Chewy&#39;s venture into veterinary services through the Chewy Health division is set to attract pet owners seeking comprehensive care for their pets. This move is expected to create cross-selling opportunities and increase customer lifetime value, further contributing to revenue growth.
<h2>CHWY Leads the Pack</h2>
Chewy has witnessed an impressive surge in its stock price over the past three months, with the stock rallying 66.7%, significantly outpacing the industry&#39;s modest increase of 0.4%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/32/75070.jpg?v=1468547690" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
CHWY has also outshined its competitors, including BARK, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bark#NYSE">BARK</a>), Petco Health and Wellness Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/woof#NASDAQ">WOOF</a>) and Central Garden &amp; Pet Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>).
While BARK shares have climbed 43.3% during the said time frame, WOOF and CENT have faced declines of 10.7% and 13.7%, respectively.
<h2>Is CHWY a Strong Case for Value Seekers?</h2>
From a valuation perspective, Chewy shares present an attractive opportunity, trading at a discount relative to historical and industry benchmarks. With a forward 12-month price-to-sales ratio of 0.98, below the five-year median of 1.72 and the industry&#39;s average of 1.73, the stock offers compelling value for investors seeking exposure to the sector.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/f5/75071.jpg?v=1476517342" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
<h2>Investment Thesis</h2>
Chewy has showcased strong performance, marked by substantial stock price appreciation, robust financial metrics and strategic initiatives. Despite its recent surge, Chewy&#39;s stock continues to offer attractive valuation metrics alongside promising growth prospects. The company&#39;s commitment to innovation, such as expanding its Autoship program and services like Chewy Health, not only strengthens customer loyalty but also opens new revenue streams. Coupled with its strategic expansion into international markets and a strong focus on operational efficiency, Chewy is well-positioned to capitalize on the growing pet care industry.
<h2>Conclusion</h2>
Investing in Chewy ahead of its second-quarter earnings release appears prudent. The company&#39;s robust growth trajectory, underpinned by its strategic focus on product expansion and enhanced customer experience, positions it for continued success. The expected revenue growth, driven by initiatives like the Autoship program and the Chewy Plus membership, highlights the company&#39;s ability to attract and retain customers.
Additionally, Chewy&#39;s expansion into international markets and the veterinary services sector reinforces its potential for long-term growth. With a strong history of surpassing earnings expectations and promising indicators for the upcoming quarter, Chewy represents an appealing investment opportunity.
<a href="https://www.zacks.com/stock/news/2325737/is-chewy-chwy-stock-a-wise-investment-ahead-of-q2-earnings?cid=CS-BENZ-FT-analyst_blog|most_popular_stocks-2325737">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Large Cap

Mid Cap

Penny Stocks

Offerings

Small Cap

Markets

BARK

CHWY

WOOF

Is Chewy Stock a Wise Investment Ahead of Q2 Earnings?

Guidance

Central Garden & Pet Sees FY24 Adj. EPS $2.00 Or Better Vs $2.19 Est.

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.21 by 9.09 percent. The company reported quarterly sales of $996.348 million which missed the analyst consensus estimate of $1.002 billion by 0.55 percent. This is a 2.61 percent decrease over sales of $1.023 billion the same period last year.

Earnings Misses

Central Garden & Pet Q3 2024 Adj. EPS $1.32 Beats $1.21 Estimate, Sales $996.348M Miss $1.002B Estimate

CORRECTION: Central Garden & Pet Company To Report On August 7, 2024

Canaccord Genuity analyst Brian McNamara maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) with a Buy and lowers the price target from $52 to $49.

Canaccord Genuity Maintains Buy on Central Garden & Pet, Lowers Price Target to $49

Argus Research analyst John Staszak upgrades Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) from Hold to Buy and announces $50 price target.

Upgrades

Argus Research Upgrades Central Garden & Pet to Buy, Announces $50 Price Target

In a new SEC filing on May 15, it was revealed that Machek, Chief Accounting Officer at Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>), executed a significant exercise of company stock options.
What Happened: Machek, Chief Accounting Officer at Central Garden &amp; Pet, exercised stock options for 10,000 shares of CENT stock. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000887733/000095017024060501//Archives/edgar/data/887733/000095017024060501/0000950170-24-060501-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The exercise price of the options was $22.8 per share.
During Thursday's morning session, Central Garden &amp; Pet shares down by 1.39%, currently priced at $46.67. Considering the current price, Machek's 10,000 shares have a total value of $238,700.
<h3>Get to Know Central Garden &amp; Pet Better</h3>
Central Garden &amp; Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
<h3>A Deep Dive into Central Garden &amp; Pet's Financials</h3>
Decline in Revenue: Over the 3 months period, Central Garden &amp; Pet faced challenges, resulting in a decline of approximately -0.98% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 30.98%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): Central Garden &amp; Pet's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.94.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.91.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 21.32, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.95 is lower than the industry average, implying a discounted valuation for Central Garden &amp; Pet's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 11.59, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000887733">Check Out The Full List Of Central Garden &amp; Pet's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options Exercise: Howard Machek At Central Garden & Pet Realizes $238K

WIIM

Central Garden & Pet shares are trading higher following a Q2 earnings beat.

Fiscal 2024 Guidance
Central continues to expect fiscal 2024 non-GAAP EPS to be $2.00 or better ($2.50 or better before the February 2024 stock dividend).
This outlook reflects uncertain consumer demand and retailer dynamics and an environment of macroeconomic and geopolitical volatility. It includes modest carryover pricing actions to help mitigate inflationary headwinds. This outlook excludes the impact of any acquisitions, divestitures or restructuring activities that may occur during fiscal 2024, including any projects under the Cost and Simplicity program and the recent TDBBS acquisition. Central expects fiscal 2024 capital spending to be approximately $70 million.

Central Garden & Pet Continues To Expect FY24 Non-GAAP EPS To Be $2.00 Or Better ($2.50 Or Better Before The February 2024 Stock Dividend) Vs $2.23 Est

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.80 by 23.75 percent. The company reported quarterly sales of $900.000 million which beat the analyst consensus estimate of $887.420 million by 1.42 percent. This is a 0.99 percent decrease over sales of $909.004 million the same period last year.

Central Garden & Pet Q2 2024 Adj EPS $0.99 Beats $0.80 Estimate, Sales $900.000M Beat $887.420M Estimate

Tractor Supply Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsco#NASDAQ">TSCO</a>) is likely to register an increase in the top and bottom lines when it reports first-quarter 2024 results on Apr 25, before market open. The Zacks Consensus Estimate for revenues is pegged at $3.40 billion, indicating a 3% jump from the year-ago reported figure. 
The bottom line of the largest rural lifestyle retailer in the United States is expected to have risen year over year. The Zacks Consensus Estimate for earnings per share for the first quarter has remained stable at $1.70 in the past 30 days, suggesting 3% growth from the year-ago period&#39;s reported figure. 
Tractor Supply has a trailing four-quarter earnings surprise of 0.5%, on average. In the last reported quarter, this Brentwood, TN-based company&#39;s earnings missed the Zacks Consensus Estimate by 2.6%.
<h3>Key Factors to Note</h3>
Tractor Supply has been experiencing momentum, driven by sturdy demand and strong market share gains. The company has been gaining from demand for its core merchandise, including consumable, usable and edible products. Its buyout of Orscheln Farm and Home, and store openings have been aiding its performance. The company has been benefiting from its Life Out Here Strategy and the Neighbor&#39;s Club membership program, which is likely to have driven its sales in the to-be-reported quarter. The strategy is essentially based on five key pillars: customers, digitization, execution, team members and total shareholder return. 
Tractor Supply has been focusing on its growth initiatives, which include the expansion of its store base and the incorporation of technological advancements to induce traffic and drive the top line. The company&#39;s Project Fusion and Side Lot model transformations have been significant investments toward stores. These store investments target achieving higher market share and boosting productivity across the existing and new stores. 
TSCO&#39;s &lsquo;ONETractor&#39; strategy, which is aimed at connecting stores and online shopping, appears encouraging too. Its omnichannel investments include curbside pickup, same-day and next-day delivery, a re-launched website and a new mobile app. The company&#39;s rebranding of Petsense by Tractor Supply and the expansion of its Neighbor&#39;s Club program to Petsense stores received positive customer feedback. This move is likely to have enabled it to gain pet customers for both banners. 
However, Tractor Supply has been grappling with higher depreciation and amortization costs, impacts of higher medical claims and inflationary pressures. Consequently, the company has been witnessing higher selling, general and administrative (SG&amp;A) expenses. Our model indicates a 3.6% rise in SG&amp;A expenses and a 50-bps increase in SG&amp;A expense rate on a year-over-year basis for the first quarter. Nonetheless, all the aforesaid strengths are likely to have boosted the company&#39;s performance in the first quarter.
<h3>What the Zacks Model Unveils</h3>
Our proven model conclusively predicts an earnings beat for Tractor Supply this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they&#39;re reported with our Earnings ESP Filter.
<div class="chart_embed">
<h3>Tractor Supply Company Price and EPS Surprise</h3>
<a href="https://www.zacks.com/stock/chart/TSCO/price-eps-surprise?icid=chart-TSCO-price-eps-surprise"><img alt="Tractor Supply Company Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/a0/1713791837.png" style="height:263px; width:544px" title="" /> </a>
Tractor Supply Company price-eps-surprise | Tractor Supply Company Quote
</div>
Tractor Supply has an Earnings ESP of +0.50% and a Zacks Rank of 2 at present.
<h3>Other Stocks Poised to Beat Earnings Estimates</h3>
Here are a few more companies that have the right combination of elements to post an earnings beat: 
Central Garden &amp; Pet (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>) currently has an Earnings ESP of +4.32% and a Zacks Rank of 1. CENT is likely to register bottom-line growth when it reports second-quarter fiscal 2024 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $894.5 million, suggesting a 1.6% drop from the figure reported in the year-ago quarter. 
The consensus estimate for CENT&#39;s fiscal second-quarter earnings is pegged at 83 cents a share, up 15.3% from the year-ago quarter. The consensus mark has risen a couple of cents in the past 30 days. 
Chipotle Mexican Grill (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmg#NYSE">CMG</a>) currently has an Earnings ESP of +1.86% and a Zacks Rank of 3. The company is expected to register top and bottom-line growth when it reports first-quarter 2024 numbers. The Zacks Consensus Estimate for CMG&#39;s quarterly revenues is pegged at $2.67 billion, which implies growth of 12.8% from the year-ago quarter&#39;s reported figure. 
The consensus estimate for Chipotle&#39;s earnings has increased 0.4% to $11.56 per share in the past seven days. The consensus estimate for earnings suggests growth of 10.1% from the year-ago quarter&#39;s reported figure. CMG has delivered an earnings beat of 9.1%, on average, in the trailing four quarters. 
Beacon Roofing Supply (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/becn#NASDAQ">BECN</a>) has an Earnings ESP of +0.82% and a Zacks Rank of 3 at present. BECN is likely to register top-line growth when it reports first-quarter 2024 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.88 billion, suggesting 8.5% growth from the figure reported in the year-ago quarter. 
The consensus estimate for Beacon Roofing&#39;s first-quarter earnings is pegged at 35 cents per share, suggesting a 47.8% decline from the figure reported in the year-ago quarter. The consensus estimate for earnings has remained unchanged in the past 30 days. BECN has delivered an earnings beat of 10.3%, on average, in the trailing four quarters.
<a href="https://www.zacks.com/stock/news/2259361/here-s-how-tractor-supply-tsco-is-placed-before-q1-earnings?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2259361">To read this article on Zacks.com click here.</a>

BECN

TSCO

Here's How Tractor Supply Is Placed Before Q1 Earnings

Canaccord Genuity analyst Brian McNamara initiates coverage on Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) with a Buy rating and announces Price Target of $52.

Initiation

Canaccord Genuity Initiates Coverage On Central Garden & Pet with Buy Rating, Announces Price Target of $52

Truist Securities analyst Bill Chappell maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) with a Buy and raises the price target from $50 to $60.

Truist Securities Maintains Buy on Central Garden & Pet, Raises Price Target to $60

Shares of Take-Two Interactive Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>) fell sharply during Friday&rsquo;s session following third-quarter results.
Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year. The company also revised its 2024 net bookings forecast to $5.25 billion and $5.3 billion, down from $5.45 billion and $5.55 billion earlier.
Take-Two Interactive Software shares dipped 8.8% to $154.69 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Sunworks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) shares jumped 267% to $0.1990. Sunworks and three subsidiaries recently made the decision to cease operations and filed for Chapter 7 bankruptcy in the United States Bankruptcy Court for the District of Delaware.</li>
<li>TOP Financial Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/top#NASDAQ">TOP</a>) gained 87.55% to $6.13.</li>
<li>NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) shares climbed 66% to $0.1932 after the company disclosed completion of financing to support restructuring process.</li>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) jumped 47.3% to $4.24 following second-quarter results.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares climbed 46% to $1.6099 after jumping over 16% on Thursday.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilag#NASDAQ">ILAG</a>) gained 45.5% to $0.6851 after surging around 24% on Thursday.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares rose 44.4% to $0.0535 after gaining 25% on Thursday.</li>
<li>Better Choice Company Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bttr#NYSE">BTTR</a>) gained 35% to $0.2379. Better Choice acquired Aimia Pet Healthco.</li>
<li>Masonite International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/door#NYSE">DOOR</a>) surged 34.5% to $129.99 after Owens Corning announced it will acquire the company for $3.9 billion.</li>
<li>Cloudflare, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/net#NYSE">NET</a>) rose 23.5% to $111.49 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) shares gained 22% to $12.81 after the company reported a year-over-year increase in first-quarter GAAP EPS and better-than-expected sales results.</li>
<li>Centessa Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnta#NASDAQ">CNTA</a>) climbed 20.5% to $8.99. Centessa Pharmaceuticals will present additional 52-weeks continuous treatment data from third year ongoing Phase 2a study of SerpinPC for treatment of hemophilia at 17th Annual Congress of European Association for Haemophilia and Allied Disorders.</li>
<li>IGM Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igms#NASDAQ">IGMS</a>) gained 19.2% to $15.44.</li>
<li>Streamline Health Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strm#NASDAQ">STRM</a>) rose 18.8% to $0.4814.</li>
<li>Natural Grocers by Vitamin Cottage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ngvc#NYSE">NGVC</a>) gained 18.2% to $17.51 following quarterly results.</li>
<li>Soho House &amp; Co Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shco#NYSE">SHCO</a>) rose 15.7% to $5.79. Soho House announced its board evaluated certain strategic transactions in the fall of 2023.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) gained 13.1% to $5.77.</li>
<li>Matrix Service Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtrx#NASDAQ">MTRX</a>) rose 13.1% to $12.82.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) gained 12.6% to $7.07.</li>
<li>Central Garden &amp; Pet Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>) rose 10.4% to $43.03. Central Garden &amp; Pet reported better-than-expected first-quarter financial results.</li>
<li>Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) gained 10.2% to $117.18 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) rose 8.2% to $5.44. B of A Securities analyst Tazeen Ahmad initiated coverage on Ocular Therapeutix with a Buy rating and announced a price target of $15.</li>
<li>Mueller Water Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mwa#NYSE">MWA</a>) gained 8% to $14.99 following upbeat results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Synlogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sybx#NASDAQ">SYBX</a>) fell 53.3% to $1.61 after the company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.</li>
<li>The Children&#39;s Place, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plce#NASDAQ">PLCE</a>) shares fell 52.7% to $9.34 after the company said it expects fourth-quarter net sales to be roughly $454 million to $456 million, versus its prior guidance of $460 million to $465 million, and below the estimate of $462.88 million.</li>
<li>BioXcel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btai#NASDAQ">BTAI</a>) fell 33.7% to $2.4882 after the company announced a proposed public offering.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) declined 33.5% to $8.62.</li>
<li>EMCORE Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/emkr#NASDAQ">EMKR</a>) fell 32% to $0.4275 after posting weak quarterly results.</li>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) declined 31% to $0.7172.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares fell 30% to $0.3791 after climbing over 96% on Thursday.</li>
<li>Lantronix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrx#NASDAQ">LTRX</a>) fell 28.8% to $4.1350 following weak sales.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares declined 27.4% to $20.81 after jumping over 59% on Thursday. The company announced it planned to join the Communications Industry Association. HOLO intends to join the Communications Industry Association to foster information technology innovation.</li>
<li>eGain Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egan#NASDAQ">EGAN</a>) fell 24.4% to $5.77 following second-quarter results.</li>
<li>AMC Networks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amcx#NASDAQ">AMCX</a>) declined 19.1% to $13.78 following weak earnings.</li>
<li>Virco Mfg. Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virc#NASDAQ">VIRC</a>) dipped 18.6% to $9.48.</li>
<li>Expedia Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/expe#NASDAQ">EXPE</a>) declined 17.6% to $131.38 after the company reported fourth-quarter financial results and named Ariane Gorin as CEO.</li>
<li>Adlai Nortye Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anl#NASDAQ">ANL</a>) fell 12.3% to $7.50.</li>
<li>Newell Brands Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwl#NASDAQ">NWL</a>) declined 11.8% to $7.45 following quarterly results.</li>
<li>Pinterest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pins#NYSE">PINS</a>) shares declined 11.4% to $36.07. Pinterest reported upbeat earnings for its fourth quarter, while sales missed estimates. The company said it sees first-quarter revenue in the range of $690 million to $705 million versus estimates of $702.36 million.</li>
<li>BILL Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bill#NYSE">BILL</a>) fell 11% to $67.40 following quarterly results.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) shares fell 10.6% to $43.98 after the company reported second-quarter financial results.</li>
<li>IBEX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibex#NASDAQ">IBEX</a>) fell 10.2% to $15.61.</li>
<li>Sensient Technologies Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sxt#NYSE">SXT</a>) fell 9.6% to $56.62 following weak earnings.</li>
<li>Owens Corning (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oc#NYSE">OC</a>) fell 6.9% to $148.43 after the company announced an agreement to acquire Masonite for $3.9 billion.</li>
<li>Magna International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mga#NYSE">MGA</a>) declined 6.5% to $54.89 after the company reported mixed quarterly results.</li>
<li>Illumina, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilmn#NASDAQ">ILMN</a>) shares declined 2.7% to $139.45 following fourth-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37034937/bitcoin-surpasses-47-000-thorchain-emerges-as-top-gainer"> Bitcoin Tops $47,000; THORChain Emerges As Top Gainer </a>

Intraday Update

Movers

AFRM

AMCX

BILL

BTAI

BTTR

CLSK

CNTA

DOOR

EGAN

EMKR

EXPE

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IBEX

IGMS

ILAG

ILMN

Intelligent Bio Solutions Inc. - Common Stock

Comments

Central Garden & Pet

Central Garden & Pet (CENT) Opzioni

Central Garden & Pet (NASDAQ:CENT) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO